, Tracking Stock Market Picks
Enter Symbol:
Becton, Dickinson And Company (BDX) [hlAlert]

up 74.49 %

Becton, Dickinson And Company (BDX) rated Buy

Posted on: Monday,  Nov 12, 2007  11:25 AM ET by Lazard Capital

Lazard Capital rated Buy Becton, Dickinson And Company (NYSE: BDX) on 11/12/2007, when the stock price was $81.92.
Since then, Becton, Dickinson And Company has gained 74.50% as of 01/27/2016's recent price of $142.95.
If you would have followed this Lazard Capital's recommendation on BDX, you would have gained 74.49% of your investment in 2998 days.

Becton, Dickinson and Co. is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BD's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2007 11:25 AM Buy
81.92 92.00
as of 8/27/2015
1 Week down  -0.43 %
1 Month down  -0.15 %
3 Months up  1.35 %
1 YTD up  29.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy